Low Dose Naltrexone
LDN for MS
Naltrexone and Cancer
Drug Side Effects
Welcome to the Low Dose Naltrexone Network. This Naltrexone news and information resource provides a variety of current updates about low dose naltrexone and the status of ongoing research, findings and studies. Find information about how naltrexone might show promise in the treatment of auto immune diseases such as fibromyalgia, degenerative neurological diseases such as multiple sclerosis, and possibly some types of cancer.
Constantly updated newsfeeds and article links provide helpful online resources for naltrexone low and dose and current opinion about how the drug naltrexone might assist in treating a variety of medical conditions.
University of California
Wrapping up multiple sclerosis at UCSFUniversity of CaliforniaMultiple sclerosis (MS) usually sets in with neurological symptoms evolving over a few hours or days – eye pain, vision loss, double vision; numbness or tingling in the hands or feet; leg weakness; loss of balance. But the gradual onset belies the ...
Star Local Media
Ride to stop multiple sclerosis begins in FriscoStar Local MediaBicyclists prepare to depart from the Embassy Suites in Frisco on Saturday morning for a two-day ride to Fort Worth. The 29th annual Bike MS Sam's Club: Round-Up Ride, hosted by the National Multiple Sclerosis Society, attracted about 2,500 cyclists ...
Here are the signs, symptoms of Multiple Sclerosismyfox8.comMultiple Sclerosis, commonly referred to as MS, affects an estimated 2.3 million people worldwide. MS is an autoimmune disease in which the immune system begins to attack healthy tissue in the central nervous system, made up of the brain, spinal cord ...
|Naltrexone Fibromyalgia Updates
Global Fibromyalgia Market Report 2016-2020 - Analysis, Technologies & Forecasts - Research and Markets - Business Wire (press release)
Tue, 03 May 2016 14:10:33 GMT
Jo-Anne Dobson prases Banbridge Fibro Friends Group at coffee morning - Banbridge Leader
Tue, 03 May 2016 09:48:00 GMT
Thurrock residents walked 117 miles in aid of fibromyalgia charity - YOURTHUROCK
Tue, 03 May 2016 08:04:15 GMT
Tonix Pharmaceuticals Completes Enrollment In Phase 3 Clinical Trial Of TNX-102 SL In Fibromyalgia - Clinical Leader
Tue, 03 May 2016 04:56:58 GMT
A Path Of Emotional Growth - ProHealth
Tue, 03 May 2016 04:08:04 GMT
May 12: National Invisible Illness Day in Nevada County and elsewhere - The Union of Grass Valley
Tue, 03 May 2016 03:43:56 GMT
Fibromyalgia patients show increased risk of hyperparathyroidism in women, new study - Bel Marra Health
Mon, 02 May 2016 17:04:17 GMT
Tonix Pharma completes enrollment in late-stage study of lead product candidate in fibromyalgia - Seeking Alpha
Mon, 02 May 2016 15:42:49 GMT
Antiviral Combo May be Next Blockbuster Fibromyalgia Drug - National Pain Report
Mon, 02 May 2016 15:24:01 GMT
Dementia Test Ably Measures Fibromyalgia-related Impairment, Study Reports - Fibromyalgia News Today
Mon, 02 May 2016 15:01:11 GMT